vs

Side-by-side financial comparison of AvalonBay Communities (AVB) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

AvalonBay Communities is the larger business by last-quarter revenue ($767.9M vs $665.5M, roughly 1.2× Natera, Inc.). AvalonBay Communities runs the higher net margin — 9040.6% vs 7.1%, a 9033.5% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 3.7%). AvalonBay Communities produced more free cash flow last quarter ($1.4B vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 3.8%).

AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

AVB vs NTRA — Head-to-Head

Bigger by revenue
AVB
AVB
1.2× larger
AVB
$767.9M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+36.1% gap
NTRA
39.8%
3.7%
AVB
Higher net margin
AVB
AVB
9033.5% more per $
AVB
9040.6%
7.1%
NTRA
More free cash flow
AVB
AVB
$1.4B more FCF
AVB
$1.4B
$37.8M
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
3.8%
AVB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AVB
AVB
NTRA
NTRA
Revenue
$767.9M
$665.5M
Net Profit
$166.0M
$47.3M
Gross Margin
Operating Margin
64.2%
-3.4%
Net Margin
9040.6%
7.1%
Revenue YoY
3.7%
39.8%
Net Profit YoY
-41.2%
187.9%
EPS (diluted)
$1.18
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVB
AVB
NTRA
NTRA
Q4 25
$767.9M
$665.5M
Q3 25
$766.8M
$592.2M
Q2 25
$760.2M
$546.6M
Q1 25
$745.9M
$501.8M
Q4 24
$740.5M
$476.1M
Q3 24
$734.3M
$439.8M
Q2 24
$726.0M
$413.4M
Q1 24
$712.9M
$367.7M
Net Profit
AVB
AVB
NTRA
NTRA
Q4 25
$166.0M
$47.3M
Q3 25
$381.3M
$-87.5M
Q2 25
$268.7M
$-100.9M
Q1 25
$236.6M
$-66.9M
Q4 24
$282.1M
$-53.8M
Q3 24
$372.5M
$-31.6M
Q2 24
$253.9M
$-37.5M
Q1 24
$173.4M
$-67.6M
Operating Margin
AVB
AVB
NTRA
NTRA
Q4 25
64.2%
-3.4%
Q3 25
65.7%
-16.5%
Q2 25
67.6%
-20.2%
Q1 25
68.5%
-15.8%
Q4 24
63.1%
-13.6%
Q3 24
65.4%
-8.9%
Q2 24
66.6%
-10.6%
Q1 24
67.2%
-20.2%
Net Margin
AVB
AVB
NTRA
NTRA
Q4 25
9040.6%
7.1%
Q3 25
49.7%
-14.8%
Q2 25
35.3%
-18.5%
Q1 25
31.7%
-13.3%
Q4 24
38.1%
-11.3%
Q3 24
50.7%
-7.2%
Q2 24
35.0%
-9.1%
Q1 24
24.3%
-18.4%
EPS (diluted)
AVB
AVB
NTRA
NTRA
Q4 25
$1.18
$0.36
Q3 25
$2.68
$-0.64
Q2 25
$1.88
$-0.74
Q1 25
$1.66
$-0.50
Q4 24
$1.99
$-0.41
Q3 24
$2.61
$-0.26
Q2 24
$1.78
$-0.30
Q1 24
$1.22
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVB
AVB
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$187.2M
Total DebtLower is stronger
$9.3B
Stockholders' EquityBook value
$11.6B
$1.7B
Total Assets
$22.2B
$2.4B
Debt / EquityLower = less leverage
0.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVB
AVB
NTRA
NTRA
Q4 25
$187.2M
Q3 25
$123.3M
$1.0M
Q2 25
$102.8M
$16.0M
Q1 25
$53.3M
$17.8M
Q4 24
$108.6M
$22.7M
Q3 24
$552.4M
$29.5M
Q2 24
$545.8M
$90.3M
Q1 24
$287.9M
$69.1M
Total Debt
AVB
AVB
NTRA
NTRA
Q4 25
$9.3B
Q3 25
$8.7B
Q2 25
$8.7B
Q1 25
$8.3B
Q4 24
$8.1B
Q3 24
$8.4B
Q2 24
$8.4B
Q1 24
$8.0B
Stockholders' Equity
AVB
AVB
NTRA
NTRA
Q4 25
$11.6B
$1.7B
Q3 25
$11.9B
$1.3B
Q2 25
$11.9B
$1.2B
Q1 25
$11.9B
$1.2B
Q4 24
$11.9B
$1.2B
Q3 24
$11.9B
$878.5M
Q2 24
$11.7B
$836.5M
Q1 24
$11.7B
$794.1M
Total Assets
AVB
AVB
NTRA
NTRA
Q4 25
$22.2B
$2.4B
Q3 25
$21.9B
$1.8B
Q2 25
$21.8B
$1.8B
Q1 25
$21.2B
$1.7B
Q4 24
$21.0B
$1.7B
Q3 24
$21.3B
$1.6B
Q2 24
$21.0B
$1.5B
Q1 24
$20.6B
$1.5B
Debt / Equity
AVB
AVB
NTRA
NTRA
Q4 25
0.80×
Q3 25
0.73×
Q2 25
0.72×
Q1 25
0.70×
Q4 24
0.68×
Q3 24
0.70×
Q2 24
0.71×
Q1 24
0.68×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVB
AVB
NTRA
NTRA
Operating Cash FlowLast quarter
$1.7B
$73.9M
Free Cash FlowOCF − Capex
$1.4B
$37.8M
FCF MarginFCF / Revenue
183.5%
5.7%
Capex IntensityCapex / Revenue
34.1%
5.4%
Cash ConversionOCF / Net Profit
10.07×
1.56×
TTM Free Cash FlowTrailing 4 quarters
$2.5B
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVB
AVB
NTRA
NTRA
Q4 25
$1.7B
$73.9M
Q3 25
$477.0M
$59.4M
Q2 25
$377.8M
$37.6M
Q1 25
$415.9M
$44.5M
Q4 24
$1.6B
$52.9M
Q3 24
$486.2M
$51.8M
Q2 24
$380.0M
$4.0M
Q1 24
$412.9M
$27.0M
Free Cash Flow
AVB
AVB
NTRA
NTRA
Q4 25
$1.4B
$37.8M
Q3 25
$402.2M
$37.0M
Q2 25
$317.1M
$11.7M
Q1 25
$367.5M
$22.6M
Q4 24
$1.4B
$34.8M
Q3 24
$434.2M
$35.5M
Q2 24
$333.0M
$-7.7M
Q1 24
$375.4M
$6.7M
FCF Margin
AVB
AVB
NTRA
NTRA
Q4 25
183.5%
5.7%
Q3 25
52.5%
6.2%
Q2 25
41.7%
2.1%
Q1 25
49.3%
4.5%
Q4 24
191.0%
7.3%
Q3 24
59.1%
8.1%
Q2 24
45.9%
-1.9%
Q1 24
52.7%
1.8%
Capex Intensity
AVB
AVB
NTRA
NTRA
Q4 25
34.1%
5.4%
Q3 25
9.8%
3.8%
Q2 25
8.0%
4.7%
Q1 25
6.5%
4.3%
Q4 24
26.1%
3.8%
Q3 24
7.1%
3.7%
Q2 24
6.5%
2.8%
Q1 24
5.3%
5.5%
Cash Conversion
AVB
AVB
NTRA
NTRA
Q4 25
10.07×
1.56×
Q3 25
1.25×
Q2 25
1.41×
Q1 25
1.76×
Q4 24
5.70×
Q3 24
1.31×
Q2 24
1.50×
Q1 24
2.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons